141595-75-7

Basic information

• Product Name: L-Leucine, N-[(hexahydro-1H-azepin-1-yl)carbonyl]-, phenylmethyl ester
• CAS NO: 141595-75-7
• Molecular Formula: C20H30N2O3
• Molecular Weight: 346.47
• Mol File: 141595-75-7.mol
• Article Data: 7

Chemical Properties

• CAS DataBase Reference: L-Leucine, N-[(hexahydro-1H-azepin-1-yl)carbonyl]-, phenylmethyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: L-Leucine, N-[(hexahydro-1H-azepin-1-yl)carbonyl]-, phenylmethyl ester(141595-75-7)
• EPA Substance Registry System: L-Leucine, N-[(hexahydro-1H-azepin-1-yl)carbonyl]-, phenylmethyl ester(141595-75-7)

Safety Data

• Hazardous Substances Data: 141595-75-7(Hazardous Substances Data)

Upstream product

• 64917-99-3 (S)-α-benzyloxycarbonyl-γ-methylbutyl isocyanate 
• 1121-92-2 heptamethyleneimine 
• 111-49-9 hexamethylene imine 
• 32315-10-9 bis(trichloromethyl) carbonate 
• 1738-69-8 L-Leucine benzyl ester 
• 1738-77-8 L-leucine benzyl ester p-toluenesulfonate 
• 530-62-1 1,1'-carbonyldiimidazole 

Downstream Products

• 248921-93-9 (S)-Azepane-1-carboxylic acid (1-{4-[bis-(4-fluoro-phenyl)-methyl]-piperazine-1-carbonyl}-3-methyl-butyl)-amide 
• 248927-05-1 (S)-Azepane-1-carboxylic acid [1-(4-benzhydryl-piperazine-1-carbonyl)-3-methyl-butyl]-amide 
• 248921-61-1 (S)-Azepane-1-carboxylic acid [1-(3,3-diphenyl-propylcarbamoyl)-3-methyl-butyl]-amide 
• 248921-60-0 (S)-Azepane-1-carboxylic acid [1-(2,2-diphenyl-ethylcarbamoyl)-3-methyl-butyl]-amide 
• 248921-59-7 (S)-Azepane-1-carboxylic acid [1-(benzhydryl-carbamoyl)-3-methyl-butyl]-amide 
• 1026234-44-5 2-[(R)-1-{(S)-2-[(Azepane-1-carbonyl)-amino]-4-methyl-pentanoylamino}-2-(1H-indol-3-yl)-ethyl]-5-phenyl-thiazole-4-carboxylic acid ethyl ester 
• 1027079-01-1 2-[(R)-1-{(S)-2-[(Azepane-1-carbonyl)-amino]-4-methyl-pentanoylamino}-2-(1H-indol-3-yl)-ethyl]-5-phenyl-oxazole-4-carboxylic acid ethyl ester 
• 1027947-60-9 2-[(R)-1-{(S)-2-[(Azepane-1-carbonyl)-amino]-4-methyl-pentanoylamino}-2-(1H-indol-3-yl)-ethyl]-5-benzyl-1H-imidazole-4-carboxylic acid ethyl ester 
• 1026099-86-4 2-[(R)-1-{(S)-2-[(Azepane-1-carbonyl)-amino]-4-methyl-pentanoylamino}-2-(1H-indol-3-yl)-ethyl]-5-benzyl-oxazole-4-carboxylic acid ethyl ester 
• 168470-76-6 2-[(R)-1-{(S)-2-[(Azepane-1-carbonyl)-amino]-4-methyl-pentanoylamino}-2-(1H-indol-3-yl)-ethyl]-5-methyl-thiazole-4-carboxylic acid ethyl ester 

Relevant articles and documents

Peptidyl calcium channel blockers

The present invention provides compounds that block calcium channels having the Formula I shown below. The present invention also provides methods of using the compounds of Formula I to treat stroke, cerebral ischemia, head trauma, or epilepsy and to pharmaceutical compositions that contain the compounds of Formula I.

Aniline derivatives as calcium channel blockers

The present invention provides compounds that block calcium channels having formula (I). The present invention also provides methods of using the compounds of formula (I) to treat stroke, cerebral ischemia, head trauma, or epilepsy and to pharmaceutical compositions that contain the compounds of formula (I).

Synthesis of a series of 4-benzyloxyaniline analogues as neuronal N-type calcium channel blockers with improved anticonvulsant and analgesic properties

In this article, the rationale for the design, synthesis, and biological evaluation of a series of N-type voltage-sensitive calcium channel (VSCC) blockers is described. N-Type VSCC blockers, such as ziconotide, have shown utility in several models of str